The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019
Typestatutory instrumentDate29 Mar 2019Articles26Versions held2Cited by8 documentsLast changed31 Dec 2020
- Preamble
- 1Citation and commencement
- 2Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004
- 3Amendment of regulation 2 (interpretation)
- 4Insertion of regulation 2A (list of countries for the purpose of the definition of “marketing authorization”
- 5Amendment of regulation 3 (sponsor of a clinical trial)
- 6Omission of regulation 4 (responsibility for functions under the Directive)
- 7Amendment of regulation 13 (supply of investigational medicinal products for the purpose of clinical trials)
- 8Amendment of regulation 15 (ethics committee opinion)
- 9Amendment of regulation 20 (authorisation procedure for clinical trials involving medicinal products with sp
- 10Amendment of regulation 21 (clinical trials conducted in third countries)
- 11Insertion of regulation 27B (publication of information)
- 12Amendment of regulation 31 (suspension or termination of clinical trial)
- 13Amendment of regulation 31A (trial master file and archiving)
- 14Amendment of regulation 33 (notification of suspected unexpected serious adverse reactions)
- 15Amendment of regulation 34 (clinical trials conducted in third countries)
- 16Amendment of regulation 35 (annual list of suspected serious adverse reactions and safety report)
- 17Amendment of regulation 36 (requirement for authorisation to manufacture or import investigational medicina
- 18Amendment of regulation 43 (qualified persons)
- 19Insertion of regulation 43A (approved country for import)
- 20Amendment of regulation 45 (suspension and revocation of manufacturing authorisation)
- 21Amendment of regulation 48 (infringement notices)
- 22Amendment of regulation 56 (transitional provisions)
- 23Insertion of regulation 57 (functions in relation to good clinical practice)
- 24Amendment of Schedule 3 (particulars and documents that must accompany an application for an ethics committ
- 25Amendment of Schedule 7 (standard provisions for manufacturing authorisations)
- 26Insertion of Schedule 13 (transitional provisions in relation to EU Exit)
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.